FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutics and can be used to produce a carrier system for targeted drug delivery in diagnostics or therapy. Disclosed is a carrier system for targeted delivery of penicillin and anthracycline-based antibiotics based on nanopowders, having magnetic properties, characterized by that it consists of amorphous nanopowder of silicon dioxide doped with manganese dioxide, wherein doping with manganese dioxide is carried out in the process of producing nanopowders by evaporation with a pulsed electron beam in a low pressure gas, and has a porosity of up to 0.88 cm3/g and specific surface area of up to 176 m2/g.
EFFECT: disclosed carrier system has high porosity and specific surface area, which determines high loading capacity, magnetic properties, which enable to control the drug delivery process, and biocompatibility.
1 cl, 3 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION AND METHOD FOR SYNTHESIS OF SCINTHILLATION CERAMICS BASED ON NANOPOWDER | 2020 |
|
RU2748274C1 |
METHOD FOR PRODUCTION OF THIN-LAYER SORBENT BASED ON MANGANESE DIOXIDE FOR ALPHA-SPECTROMETRIC DETECTION OF RADIUM ISOTOPES | 2021 |
|
RU2780727C1 |
SYSTEM FOR SETTING UP A MAGNETIC SENSOR THAT DETECTS A MAGNETIC VEHICLE WITH A MEDICINAL PRODUCT IN THE THERAPY AREA | 2022 |
|
RU2801443C1 |
METHOD FOR PRODUCING PHOTO-SENSITIVE LEAD SULFIDE FILMS | 2022 |
|
RU2783294C1 |
METHOD FOR OBTAINING PHOTOSENSITIVE LEAD SULPHIDE FILMS | 2023 |
|
RU2808317C1 |
METHOD FOR OBTAINING OPTICALLY TRANSPARENT CERAMICS BASED ON LUTETIUM OXIDE | 2017 |
|
RU2671550C1 |
METHOD OF PRODUCING NANOSIZED SYSTEM FOR DELIVERING AZIDOTHYMIDINE TRIPHOSPHATE TO MAMMALIAN CELLS | 2014 |
|
RU2563171C1 |
METHOD FOR PREPARING NUTRIENT MEDIUM FOR CULTIVATION OF YEAST XANTHOPHYLLOMYCES DENDRORHOUS (PHAFFIA RHODOZYMA) BASED ON SOYBEAN MELACE AND YEAST EXTRACT | 2022 |
|
RU2785792C1 |
METHOD OF PRODUCING COMPOSITE OXIDE MATERIALS | 2019 |
|
RU2733966C1 |
METHOD FOR PREPARING PHARMACEUTICALLY ACCEPTABLE DOSAGE FORMS AND USING THEM IN COMBINED CHEMOTHERAPY AND PHOTODYNAMIC THERAPY OF MALIGNANT NEOPLASMS | 2023 |
|
RU2822629C1 |
Authors
Dates
2019-12-12—Published
2018-12-27—Filed